论文部分内容阅读
婴幼儿哮喘症状常不典型,有的迁延数年尚未得到确诊,而拟为炎症而误用了大量抗生素。究其病因,多由呼吸道感染病毒而诱发,至于具有特异体质的儿童,由于遗传因素或免疫调节紊乱,亦可作为变应原刺激机体产生病毒特异性IgE,与相应病毒抗原结合,促使组织胺等介质释放,引致哮喘发作。针对此一机制,乃选用细胞免疫调节剂小牛胸腺肽治疗30例婴幼儿哮喘,取得满意疗效,现总结如下: 1 临床资料 1.1 纳入对象 选择1995～1996 a哮喘专科门诊及部分住院病人,均符合婴幼儿哮喘的诊断标准。治疗组30例,男性18例,女性12例;年龄:
Infants and young children are often atypical asthma symptoms, and some have not yet been diagnosed for some years of delay, and intended for the inflammation and misuse of a large number of antibiotics. The etiology, mostly caused by the respiratory tract infection virus, as children with specific constitution, due to genetic factors or immune regulation disorders, can also be used as an allergen to stimulate the body to produce virus-specific IgE, with the corresponding viral antigen, promote histamine Other media release, causing asthma attacks. In view of this mechanism, is the use of cellular calf thymus peptide therapy in 30 cases of infant asthma, and achieved satisfactory results, are summarized as follows: 1 clinical data 1.1 included in the target selection 1995 ~ 1996 a asthma specialist outpatient and some inpatients are in line with Diagnostic criteria for infant asthma. Treatment group, 30 cases, 18 males and 12 females; Age: